Cor Vasa 2013, 55(1):e7-e14 | DOI: 10.1016/j.crvasa.2012.10.004

Cardiology department hospitalization costs in patients with acute heart failure vary according to the etiology of the acute heart failure: Data from the AHEAD Core registry 2005-2009

Barbora Říhováa, Jiří Pařenicab,c,d,*, Jiří Jarkovskýe, Roman Miklíka,d, Alexandra Šulcováa,f, Simona Littnerováe, Marián Felšöcib, Petr Kalab,c, Jindřich Špinarb,c,d
a Farmakologický ústav, Lékařská fakulta Masarykovy univerzity, Brno, Česká republika
b Interní kardiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice Brno, Brno, Česká republika
c Lékařská fakulta Masarykovy univerzity, Brno, Česká republika
d International Clinical Research Center - I. interní kardioangiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice u sv. Anny, Brno, Česká republika
e Institut biostatistiky a analýz, Masarykova univerzita, Brno, Česká republika
f CEITEC - Central European Institute of Technology, Masarykova univerzita, Brno, Česká republika

Background: To assess the distribution of costs associated with Cardiology Unit hospitalization due to acute heart failure (AHF) and evaluate, from the perspective of the healthcare payer, the heterogeneity of resources use according to AHF etiology in patients from 2005 to 2009.

Methods: The type and etiology of AHF was determined upon hospital admission. The cost of in-patient care was based on the individual hospital account of each patient (1759 patients in total; 58.7% male; mean age 71 years).

Results: The median hospital stay was 7 days and the mean total cost of in-patient care was €3364. A Coronary Care Unit (CCU) stay was recorded in 67.4% patients (median 3 days). Significantly higher costs were found in de-novo AHF patients (mean €3678) with a greater need for CCU care, a longer stay in the CCU and a greater need for intervention (particularly that of percutaneous coronary intervention [PCI]), than in patients with acute decompensation of chronic heart failure (mean cost €2878; p < 0.001). Acute coronary syndrome was a major precipitating factor, with the highest costs (€4429) resulting from having received PCI (63.3% of patients) and CCU admission (91.7% of patients). Variations in length of stay according to AHF etiology were minor (median, 6-8 days). In-hospital mortality was 15.0%.

Conclusions: Hospitalization costs as they relate to AHF are high, particularly in new-onset AHF patients. The heterogeneity of resources use is largely a reflection of interventions undertaken, particularly if revascularization or anti-arrhythmic therapy is provided.

Keywords: AHEAD registry; Heart failure; In-hospital costs

Received: June 24, 2012; Revised: October 21, 2012; Accepted: October 22, 2012; Published: February 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Říhová B, Pařenica J, Jarkovský J, Miklík R, Šulcová A, Littnerová S, et al.. Cardiology department hospitalization costs in patients with acute heart failure vary according to the etiology of the acute heart failure: Data from the AHEAD Core registry 2005-2009. Cor Vasa. 2013;55(1):e7-14. doi: 10.1016/j.crvasa.2012.10.004.
Download citation

References

  1. M.S. Nieminen, M. Böhm, M.R. Cowie, et al., Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology, European Heart Journal 26 (2005) 384-416. Go to original source...
  2. J.G. Cleland, K. Swedberg, F. Follath, et al., The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis, European Heart Journal 24 (2003) 442-463. Go to original source... Go to PubMed...
  3. M. Komajda, F. Follath, K. Swedberg, et al., The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment, European Heart Journal 24 (2003) 464-474. Go to original source...
  4. M.S. Nieminen, D. Brutsaert, K. Dickstein, et al., EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population, European Heart Journal 27 (2006) 2725-2736. Go to original source... Go to PubMed...
  5. K. Siirila-Waris, J. Lassus, J. Melin, et al., Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure, European Heart Journal 27 (2006) 3011-3017. Go to original source... Go to PubMed...
  6. J. Spinar, J. Parenica J. Vitovec, et al., Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry, Critical Care 15 (2011) R291. Go to original source... Go to PubMed...
  7. C. Berry, D.R. Murdoch, J.J. McMurray, Economics of chronic heart failure, European Journal of Heart Failure 3 (2001) 283-291. Go to original source...
  8. Czech National Bank. [http://www.cnb.cz]
  9. K.F. Adams, G.C. Fonarow, C.L. Emerman, et al., Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE), American Heart Journal 149 (2005) 209-216. Go to original source... Go to PubMed...
  10. G.C. Fonarow, W.T. Abraham, N.M. Albert, et al., Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF, Archives of Internal Medicine 168 (2008) 847-854. Go to original source... Go to PubMed...
  11. W.T. Abraham, G.C. Fonarow, N.M. Albert, et al., Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF), Journal of the American College of Cardiology 52 (2008) 347-356. Go to original source... Go to PubMed...
  12. W.T. Abraham, K.F. Adams, G.C. Fonarow, et al., In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE), Journal of the American College of Cardiology 46 (2005) 57-64. Go to original source... Go to PubMed...
  13. J.L. Januzzi, R. van Kimmenade, J. Lainchbury, et al., NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study, European Heart Journal 27 (2006) 330-337. Go to original source... Go to PubMed...
  14. G.C. Fonarow, W.F. Peacock, C.O. Phillips, et al., Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure, Journal of the American College of Cardiology 49 (2007) 1943-1950. Go to original source... Go to PubMed...
  15. F. Zannad, A. Mebazaa, Y. Juilliere, et al., Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study, European Journal of Heart Failure 8 (2006) 697-705. Go to original source... Go to PubMed...
  16. V.P. Harjola, S. Costa, R. Sund, et al., The type of acute heart failure and the costs of hospitalization, International Journal of Cardiology 145 (2010) 103-105. Go to original source... Go to PubMed...
  17. P.J. Hauptman, J. Swindle, T.E. Burroughs, M.A. Schnitzler, Resource utilization in patients hospitalized with heart failure: Insights from a contemporary national hospital database, American Heart Journal 155 (2008) 978-985. Go to original source... Go to PubMed...
  18. European Central Bank, ECB reference exchange rate, US dollar/Euro, 2:15 pm (C.E.T.). EXR 2005: USD 1.2441 = € 1. [http://sdw.ecb.europa.eu/quickview.do?SERIES_KEY=120.EXR.D.USD.EUR.SP00.A]
  19. G. de Lissovoy, K. Fraeman, J.R. Teerlink, et al., Hospital costs for treatment of acute heart failure: economic analysis of REVIVE II study, European Journal of Health Economics 11 (2010) 185-193. Go to original source... Go to PubMed...
  20. B. Ondrackova, J. Parenica, R. Miklik, et al., Pharmacoeconomic analysis of costs related to management by cardiac surgery of patients hospitalized for acute heart failure, Cor et Vasa 52 (2010) 684-689. Go to original source...
  21. M. Drummond, M. Barbieri, J. Cook, et al., Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report, Value in Health 12 (2009) 409-418. Go to original source... Go to PubMed...
  22. A. Haycox, A. Bagust, Pharmacoeconomics and clinical trials, in: T. Walley, A. Haycox, A. Boland (Eds.), Pharmacoeconomics, Elsevier Science Limited, Edinburgh: Churchill Livingstone, 2004, pp. 127-140.
  23. M.F. Drummond, M.J. Sculpher, G.W. Torrance, et al., Presentation and use of economic evaluation results, in: M.F. Drummond, M.J. Sculpher, G.W. Torrance, B.J. O'Brien, G.L. Stoddart (Eds.), Methods for the Economic Evaluation of Health Care Programmes, Third Edition, Oxford University Press, New York, 2005, pp. 323-364. Go to original source...
  24. H.A. Glick, J.A. Doshi, S.S. Sonnad, D. Polsky, Transferability of the results from trials, in: H.A. Glick, J.A. Doshi, S.S. Sonnad, D. Polsky (Eds.), Economic Evaluation in Clinical Trials, Oxford University Press, New York, 2007, pp. 207-228 (reprinted 2010).




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.